All lobbying filings

EXELIXIS INC.

EXELIXIS INC. filed a Q1 report for EXELIXIS INC. on April 18, 2025.

Lobbying for EXELIXIS INC.

All filings by EXELIXIS INC. · Everything EXELIXIS INC. has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 18, 2025

Expenses

$460,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

California

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Proposals related to drug pricing, including implementation of related provisions of the Inflation Reduction Act. Administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act. Intellectual property proposals relating to life sciences. Reintroduction of the Small Biotech Innovation Act. Health agency funding levels.

Taxation/Internal Revenue Code

IRC Section 174 amortization of R&D expenditures.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.